Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Intragenic DNA methylation in transcriptional regulation, normal differentiation and cancer
M Kulis, AC Queirós, R Beekman… - Biochimica et Biophysica …, 2013 - Elsevier
Ever since the discovery of DNA methylation at cytosine residues, the role of this so called
fifth base has been extensively studied and debated. Until recently, the majority of DNA …
fifth base has been extensively studied and debated. Until recently, the majority of DNA …
Transformation of indolent B-cell lymphomas
S Montoto, J Fitzgibbon - Journal of clinical oncology, 2011 - ascopubs.org
Histologic transformation (HT) to an aggressive lymphoma is a well-described event in the
natural history and clinical course of patients with so-called indolent lymphomas. This …
natural history and clinical course of patients with so-called indolent lymphomas. This …
Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
Follicular lymphoma (FL) and the GCB subtype of diffuse large B-cell lymphoma (DLBCL)
derive from germinal center B cells. Targeted resequencing studies have revealed mutations …
derive from germinal center B cells. Targeted resequencing studies have revealed mutations …
Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas
EZH2, the catalytic subunit of the PRC2 complex, catalyzes the mono-through trimethylation
of lysine 27 on histone H3 (H3K27). Histone H3K27 trimethylation is a mechanism for …
of lysine 27 on histone H3 (H3K27). Histone H3K27 trimethylation is a mechanism for …
Whole-genome fingerprint of the DNA methylome during human B cell differentiation
We analyzed the DNA methylome of ten subpopulations spanning the entire B cell
differentiation program by whole-genome bisulfite sequencing and high-density microarrays …
differentiation program by whole-genome bisulfite sequencing and high-density microarrays …
DNA methylation profiling identifies epigenetic dysregulation in pancreatic islets from type 2 diabetic patients
M Volkmar, S Dedeurwaerder, DA Cunha… - The EMBO …, 2012 - embopress.org
In addition to genetic predisposition, environmental and lifestyle factors contribute to the
pathogenesis of type 2 diabetes (T2D). Epigenetic changes may provide the link for …
pathogenesis of type 2 diabetes (T2D). Epigenetic changes may provide the link for …
EZH2-mediated epigenetic silencing in germinal center B cells contributes to proliferation and lymphomagenesis
I Velichutina, R Shaknovich, H Geng… - Blood, The Journal …, 2010 - ashpublications.org
EZH2 is the catalytic subunit of the PRC2 Polycomb complex and mediates transcriptional
repression through its histone methyltransferase activity. EZH2 is up-regulated in normal …
repression through its histone methyltransferase activity. EZH2 is up-regulated in normal …
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs in hematological malignancies
The indisputable role of epigenetics in cancer and the fact that epigenetic alterations can be
reversed have favoured development of epigenetic drugs. In this study, we design and …
reversed have favoured development of epigenetic drugs. In this study, we design and …
Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns
Introduction Five different molecular subtypes of breast cancer have been identified through
gene expression profiling. Each subtype has a characteristic expression pattern suggested …
gene expression profiling. Each subtype has a characteristic expression pattern suggested …
[HTML][HTML] A687V EZH2 is a gain-of-function mutation found in lymphoma patients
CR Majer, L **, MP Scott, SK Knutson, KW Kuntz… - FEBS letters, 2012 - Elsevier
Heterozygous point mutations at Y641 and A677 in the EZH2 SET domain are prevalent in
about 10–24% of Non-Hodgkin lymphomas (NHL). Previous studies indicate that these are …
about 10–24% of Non-Hodgkin lymphomas (NHL). Previous studies indicate that these are …